Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

出版年份 2012 全文链接

标题

作者

关键词

出版物

Volume 30, Issue 18, Pages 2190-2196

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2012-05-22

DOI

10.1200/jco.2011.38.0402

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now